(Q53084647)

11 May 2018

title

Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study. (English)

1 reference

11 May 2018

1 reference

9

Adnan Kastrati

1 reference

11 May 2018

8

Karl-Ludwig Laugwitz

1 reference

11 May 2018

Isabell Bernlochner

1

1 reference

11 May 2018

Katharina Mayer

2

1 reference

11 May 2018

Martin Orban

3

1 reference

11 May 2018

Tanja Morath

4

1 reference

11 May 2018

Juliane Jaitner

5

1 reference

11 May 2018

Lisa Rössner

6

1 reference

11 May 2018

Lisa Gross

7

1 reference

11 May 2018

Dirk Sibbing

10

1 reference

11 May 2018

publication date

8 June 2016

1 reference

11 May 2018

published in

Platelets

1 reference

11 May 2018

volume

27

1 reference

11 May 2018

issue

8

1 reference

11 May 2018

page(s)

796-804

1 reference

11 May 2018

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

The disposition of prasugrel, a novel thienopyridine, in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Pharmacodynamic evaluation of switching from ticagrelor to prasugrel in patients with stable coronary artery disease: Results of the SWAP-2 Study (Switching Anti Platelet-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (IS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Comparison of therapy with Ticagrelor, Prasugrel or high Clopidogrel dose in PCI patients with high on treatment platelet reactivity and genotype variation. TRIPLETE RESET trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Selective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Bedside evaluation of thienopyridine antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Impact of immature platelets on platelet response to ticagrelor and prasugrel in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Inter-patient variability and impact of proton pump inhibitors on platelet reactivity after prasugrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

Increased platelet inhibition after switching from maintenance clopidogrel to prasugrel in patients with acute coronary syndromes: results of the SWAP (SWitching Anti Platelet) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

A comparative pharmacodynamic study of ticagrelor versus clopidogrel and ticagrelor in patients undergoing primary percutaneous coronary intervention: the CAPITAL RELOAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537104.2016.1190007

10.1080/09537104.2016.1190007

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018